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Summary
Background Excess body fat is associated with an increase in risk of type 2 diabetes and hypertension in adulthood and 
these risks can adversely aﬀ ect progression of arterial disease. We aimed to assess the impact of lifelong patterns of 
adiposity on cardiovascular risk factors and carotid intima media thickness (cIMT) in later life in participants in the 
1946 British birth cohort study.
Methods The National Survey of Health and Development Study was a nationally representative sample of 5362 singleton 
births to married parents in England, Scotland, and Wales, stratiﬁ ed by social class, during 1 week in March 1946. Our 
present study is based on the 60% of participants still alive and with a known present address in England, Scotland, or 
Wales who attended a clinic assessment after invitation aged 60–64 years. We included participants with lifetime adiposity 
measures, cardiovascular risk factors, and cIMT measured at 60–64 years. Participants were classiﬁ ed as normal weight or 
overweight or obese at each age (36, 43, 53, and 60–64 years) in adulthood, and childhood overweight was deﬁ ned. Patterns 
of BMI change were identiﬁ ed and we used BMI to deﬁ ne adiposity status. We used multivariable linear regression to 
establish the cross-sectional association of BMI category at age 60–64 years with cIMT, adjusted for various confounders.
Findings We included 1273 (45%) of 2856 participants eligible in 2006–10 (at age 60–64 years) in this study. Compared 
with normal weight, overweight and obesity were associated with higher cIMT (0·029 mm, 95% CI 0·014–0·043) and 
systolic blood pressure (7·95 mm Hg, 5·86–10·0). Increased cIMT, systolic blood pressure, leptin, prevalence of 
diabetes, and reduced adiponectin were all associated with duration of exposure to adult adiposity (p<0·0001 for all). 
We noted little additional eﬀ ect of childhood overweight. Individuals who dropped a BMI category in adulthood had 
lower cIMT (–0·034 mm, –0·056 to –0·013) and leptin concentrations (–0·4 ng/mL, –0·47 to –0·32), even when this 
change was not maintained, than did those who never lost weight.
Interpretation Longer exposure to high adiposity in adulthood had a cumulative adverse eﬀ ect on cardiovascular 
phenotype in later life. Reductions in BMI category, even if not sustained, were associated with decreases in cIMT and 
improvements in cardiovascular risk-factor proﬁ le, suggesting that weight loss, at any age in adulthood, is worthwhile 
because it might result in long-term cardiovascular beneﬁ t.
Funding Medical Research Council and the British Heart Foundation.
Introduction
The upward trend in prevalence of overweight and 
obesity is a worldwide problem and is estimated that 
about 1 billion people are now overweight and more than 
300 million people are obese.1,2 Excess body fat is 
associated with increased risk of type 2 diabetes and 
hypertension in adulthood, and accumulating evidence 
shows that these risks adversely aﬀ ect progression of 
arterial disease.1,3–7 Reductions in weight achieved by 
lifestyle interventions have been associated with 
improvements in cardiovascular risk factors,8,9 although 
not necessarily with cardiovascular outcomes.10 However, 
sustained weight loss is challenging and most people 
maintain or regain their overweight or obese status in 
the long term.11
The Medical Research Council National Survey of 
Health and Development (NSHD) study, established at 
the beginning of the modern welfare state, is the longest 
prospective British cohort study to provide information 
about developmental and environmental inﬂ uences from 
birth through to early old age. The cohort underwent 
detailed cardiovascular phenotyping between the ages of 
60 and 64 years, which provided a unique opportunity to 
assess the eﬀ ect of lifetime exposure to adiposity on 
cardiovascular risk factors and arterial phenotype at this 
age. The many recordings of weight and BMI obtained 
over the lifecourse of patients in the NSHD study enabled 
us to investigate the eﬀ ect of lifetime patterns of weight 
change, and speciﬁ cally, to examine any cardiovascular 
health beneﬁ t from reduction in BMI at diﬀ erent ages.
Methods
S tudy design and participants  
The NSHD study was a nationally representative sample 
of 5362 singleton births to married parents in England, 
Scotland, and Wales, stratiﬁ ed by social class, during 
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1 week in March 1946. The cohort has been followed-up 
23 times since birth.12 Study members still alive and with 
a known present address in England, Scotland, or Wales 
were invited for either an assessment at one of six clinical 
research facilities or for home visitation from a research 
nurse at the ages of 60–64 years. Our present study is 
based on the 60% of participants who attended for a 
clinic assessment. Participants in this study had some 
diﬀ erences in their clinical characteristics compared 
with the original cohort, with lower levels of adiposity 
and lifetime smoking exposure, and higher levels of 
physical activity.13,14
Ethics approval was obtained from the Greater 
Manchester and the Scotland Research Ethics 
Committees. Participants provided written informed 
consent.
Procedures
We measured carotid intima media thickness (cIMT) in 
the right and left common carotid artery of participants 
using a high resolution scanner (Vivid I [12MHz probe]; 
GE Healthcare).15 10s cineloops were recorded in Digital 
Imaging and Communications in Medicine format and 
downloaded for oﬄ  ine analysis in the core laboratory 
(Vascular Physiology Unit, University College of London) 
with the Carotid Analyser software package (version 5.8.1). 
Three end-diastolic frames from the lateral views were 
analysed for mean cIMT. All images were analysed by 
two trained readers who were masked to participants’ 
characteristics; intra-reader and inter-reader reproducibility 
were assessed on a subset of ten randomly selected images. 
Intra-class and inter-class correlations were more than 0·9. 
Carotid plaques were deﬁ ned as cIMTs of greater than 
1·5 mm, with abnormal shape, and with an abnormal wall 
texture. In 13 people, carotid plaque was identiﬁ ed in the 
area where the cIMT measurement was done and cIMT 
measurements were unreliable, so they were excluded 
from the analysis.
Weight and height were measured during childhood 
(at ages 2, 4, 6, 7, and 11 years) and adulthood (at ages 36, 
43, 53 and 60–64 years): BMI was calculated as weight 
(kg) divided by height (m²). Waist circumference was 
measured at the same ages in adulthood. BMI was used 
to deﬁ ne adiposity status (BMI <25 kg/m² normal 
weight, 25–29 kg/m² overweight, and ≥30 kg/m² obese) 
at each age in adulthood. Adults who did not have BMI 
recorded were not included in the longitudinal analysis. 
In childhood, overweight and obesity were deﬁ ned with 
age-speciﬁ c and sex-speciﬁ c BMI thresholds proposed by 
the International Obesity Taskforce.16 Participants were 
deﬁ ned as overweight or obese in childhood if their BMI 
was in that category on at least one of the ﬁ ve 
measurements in childhood.
Blood pressure was measured twice at ages 36, 43, 53, 
and 60–64 years, with the participant in a seated position. 
We used the second reading for the analysis. 
Hypertension in adulthood was deﬁ ned as a blood 
pressure of 140/90 mm Hg or more. We classed people 
as ever hypertensive if their blood pressure had been 
greater than 140/90 mm Hg at any time since age 
36 years. We identiﬁ ed smoking status from self-
reported question naires completed between ages 
60 and 64 years; individuals were categorised into 
present smokers, ex-smokers, and non-smokers. 
Participants were asked if they were receiving lipid or 
blood-pressure-lowering drugs.
Non-fasting blood samples were obtained during home 
visits at age 53 years and overnight fasting blood samples 
were obtained at age 60–64 years.12 Details of the 
biochemical assay used to estimate total cholesterol, 
HDL cholesterol, and triglycerides have been previously 
published.17 HbA1c was measured with high-performance 
liquid chromatography using the Tosoh A1c 2.2 analyser 
(Tosoh, Tokyo, Japan). C-reactive protein was measured 
colorimetrically with a Siemens Dimension Xpand 
analyser at the Medical Research Council Human 
Nutrition Research laboratory in Cambridge. 
Concentrations of leptin, adiponectin, and high-
sensitivity interleukin-6 were measured with ELISA 
(R&D systems, Abingdon, UK).
We assessed physical activity in leisure time at ages 36, 
43, 53, and 60–64 years with self-reported activity 
questionnaires: the Minnesota Leisure-Time Physical 
Activity Questionnaire at 36 years, and more basic non-
validated questions, as previously described, at 43, 53, 
and 60–64 years and older.18 We generated a long-term 
single activity score that distinguished those who were 
active (more than one to ﬁ ve times a month) at every age 
from those who were active on at least one occasion and 
those who were inactive at all ages. Participants’ 
occupational social class at age 53 years (grouped into six 
categories according to the UK Registrar General’s 
classiﬁ cation) was used as a measure of adult 
socioeconomic position because many individuals were 
retired at the time of the clinic visit.
Statistical analysis  
We made comparisons between individuals who were 
normal weight, overweight, and obese for cardiovascular 
risk factors and cIMT by ANOVA for parametric measures 
and Kruskal Wallis test for non-parametric measures. 
Potential confounding and mediating variables were sex, 
systolic blood pressure at age 60–64 years, occupational 
social class at age 53 years, and other cardiovascular risk 
factors (heart rate and smoking status at age 60–64 years) 
and physical activity score in adulthood, and those 
associated with intima media thickness and obesity at 
p<0·05. We used multivariable linear regression to 
establish the cross-sectional association of BMI category 
at age 60–64 years with cIMT, adjusted for various 
confounders. Confounders were either selected a priori—
eg, sex and occupational social class—or were those 
variables that were associated with both cIMT and obesity 
in univariable models (p<0·05).
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We compared the mean cIMT for children categorised 
as overweight or obese with that of normal weight 
children, then added overweight or obese adults 
(60–64 years) to the model to assess whether overweight 
or obesity in childhood was independently related to 
cIMT. Mean cIMT was then compared across four groups 
of individuals: those who were of normal weight in 
childhood and adulthood (60–64 years); those who were 
of normal weight in childhood, but were overweight or 
obese in adulthood; those who were overweight or obese 
in childhood but were of normal weight in adulthood; 
and those who were overweight or obese in both periods. 
Additionally, we assessed whether overweight or obesity 
in childhood modiﬁ ed the eﬀ ect of the adult condition by 
testing the interaction term.
We grouped individuals according to seven diﬀ erent 
patterns of BMI change across adulthood: (a) those who 
maintained normal weight; (b) those who were 
overweight at age 36 years and did not subsequently 
drop a weight category (from obese to overweight or 
overweight to obese); groups c–e were the same as for b, 
but included individuals ﬁ rst recorded as overweight or 
obese at age 43, 53, or 60–64 years, respectively; (f ) those 
who were overweight or obese at some point, but who 
dropped a category (from obese to overweight or 
overweight to normal) and did not regain; and (g) those 
who were overweight or obese at some point and who 
dropped a category, but subsequently regained.
We did a test for trend across the four age-at-ﬁ rst- 
overweight-or-obesity groups (b–e), with participants in 
the never overweight or obese group (a) as the baseline, 
then tested whether the association was modiﬁ ed by 
physical activity. We then combined the four overweight 
or obese groups (b–e) and compared mean cIMT in this 
combined group (in which patients never dropped a BMI 
category once they reached overweight or obesity) with 
the two groups who did drop a category (f and g). Analyses 
were repeated with cardiovascular risk factors and 
inﬂ ammatory markers as outcome measures. We did a 
complete case analysis for the association between BMI 
change and cIMT because sensitivity analysis showed 
that participants with missing BMI (n=191) at some point 
in adulthood did not have diﬀ erent cIMT or weight 
compared with those who did not have missing values 
(appendix).
Analyses of adult onset adiposity were repeated for 
waist circumference with WHO cutoﬀ  points for men 
and women.19 Statistical analyses were done with STATA 
(version 12.1) software.
Role of the funding source  
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had ﬁ nal responsibility for 
the decision to submit for publication.
Results
Figure 1 shows the trial proﬁ le. We included 1273 (45%) 
of 2856 participants eligible in 2006–10 (at age 
60–64 years) in this study. In childhood, 926 (73%) 
individuals were overweight or obese on at least one 
measurement in childhood. In adulthood, from age 
36 years, the prevalence of overweight or obesity 
increased from 311 (27%) of 1152 patients to 845 (67%) of 
1270 patients during 27 years of follow up. Of the 
926 children who were either overweight or obese, 
621 (67%) remained overweight or obese as adults and 
302 (33%) had normal weight at ages 60–64 years.
Whereas 141 (13%) of 1082 people had a reduction in 
BMI category during 27 years of follow up, with 
subsequent regain, only 17 (2%) people had a sustained 
reduction in BMI category in adulthood.
At age 60–64 years, compared with the normal weight 
group, overweight or obese participants had a higher 
cIMT (mean diﬀ erence 0·03 mm, 95% CI 0·015–0·045; 
p<0·0001; table 1). This association remained after 
adjustment for cardiovascular risk factors (0·02 mm, 
0·005–0·036; p=0·009).
Additionally, overweight or obese individuals had an 
adverse cardiovascular risk factor proﬁ le, with increased 
concentrations of inﬂ ammatory markers, leptin, and 
2506 invitations not sent
  778 died   
  570 living abroad
 1158 withdrawn or
  lost to follow-up
2856 eligible at 2006–10 
 (aged 60–64 years)
539 had a home visit1690 attended a clinical 
 research facility
5362 original births recruited in 1946
417 excluded
  89 did not have cIMT
 328 did not have valid 
   right or left cIMT*
2229 assessed
1273 included with valid right and left cIMT
 3 did not have BMI at 2006–10: 1270 included in the adult analysis of 
  adiposity and cardiovascular phenotype
191 did not have BMI at some point in adulthood (1982 to 2006–10): 1082 
  included in the longitudinal analysis of lifetime exposure to adiposity and 
  cardiovascular phenotype
Figure 1: Patient ﬂ ow diagram
cIMT=carotid intima media thickness. *13 (4%) of 328 people had plaques.
See Online for appendix
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HbA1c (p<0·0001 for all; table 1). Systolic and diastolic 
blood pressure was also higher in overweight or obese 
participants than in those with a normal weight (table 1). 
The odds ratio of type 2 diabetes for the overweight or 
obese group versus the normal weight group was 2·48 
(95% CI 1·37–4·47; p=0·003). Concentrations of total 
cholesterol were lower in participants in the overweight 
or obese group than in those in the normal weight group 
(table 1); however, this diﬀ erence was greatly reduced 
with adjustment for lipid-lowering drugs as a binary 
variable (data not shown).
Childhood overweight or obesity was not associated 
with cIMT at age 60–64 years and did not change the 
association between adulthood overweight or obesity and 
cIMT. Thus, cIMT in participants who were overweight 
or obese in childhood but normal weight in adulthood 
was similar to that in those who were normal weight at 
both periods (table 2). In adulthood, we noted a graded 
cumulative eﬀ ect of exposure to adiposity on cIMT at age 
60–64 years, so that individuals who were classiﬁ ed as 
overweight or obese at age 36 years had the highest cIMT, 
even after adjustment for cardiovascular risk factors 
(p value for trend <0·0001; ﬁ gure 2). This association was 
not changed by physical activity. The association between 
age at onset of adulthood adiposity and cIMT was similar 
when analysis was done with waist circumference 
instead of BMI (appendix). Similar associations were 
noted for cardiometabolic risk factors: earlier onset of 
adiposity in adulthood was associated with increased 
systolic blood pressure (mean diﬀ erence per decade 
2·13 mm Hg, 95% CI 1·39–2·90; p value for trend 
<0·0001), leptin (mean diﬀ erence per decade 1·33 ng/mL, 
1·29–1·37; p<0·0001), prevalence of diabetes (OR per 
decade 1·68, 1·34–2·11; p<0·0001) and lower adiponectin 
(mean reduction per decade 1·46 μg/ml, 1·08–1·84; 
p<0·0001; appendix).
Participants overweight at 36 years and never dropping 
a BMI category during adulthood had a higher cIMT 
than those dropping a BMI category (obese to overweight 
or overweight to normal) at any time, even if this pattern 
was not sustained (cIMT lower by an average of 0·03 mm. 
95% CI 0·01–0·06; p=0·002), and than those who were 
always of normal weight (cIMT lower by an average of 
0·03 mm, 0·03–0·05; p=0·001). When analysis was done 
with waist circumference rather than BMI to deﬁ ne 
adiposity category, the drop in adiposity category, even if 
not sustained in adult life, was associated with reduced 
cIMT in women (appendix).
We noted similar associations with cardiometabolic 
risk factors: individuals who were always overweight or 
obese in adulthood had higher concentrations of HbA1c 
(p=0·04) and leptin (p<0·0001), and lower concentrations 
of adiponectin (p<0·0001) compared with those who lost 
weight and those who remained lean. However, we 
recorded no association between patterns of BMI change 
and LDL cholesterol, smoking, prevalence of type 2 
diabetes, or C-reactive protein.
Discussion
Our ﬁ ndings for the oldest British cohort, followed-up 
for up to 64 years, show that length of exposure to 
Normal weight 
(n=425)
Overweight 
(n=553)
Obese
(n=292)
p value 
(normal vs 
overweight 
or obese)
Anthropometric measurements
Men 165 (38%) 295 (53%) 141 (48%) <0·0001
Age (years) 63·2 (1·2) 63·1  (1·2) 63·3  (1·1) 0·2
Systolic blood pressure (mmHg) 129·7 (16·6) 137·8 (18·2) 139·2 (19·6) <0·0001
Diastolic blood pressure 
(mm Hg)
74·3 (9·3) 78·7 (9·6) 78·9 (9·9) <0·0001
Pulse pressure (mm Hg) 55·4 (11·8) 59·2 (13·2) 60·3 (15·2) <0·0001
Heart rate (beats per min) 68 (11·4) 68·3 (10·2) 69·5 (11·1) 0·006
Waist circumference (cm) 84 (7·8) 95·6 (7·6) 108·2 (8·0) <0·0001
Weight (kg) 65·2 (8·7) 77·9 (9·6) 93·5 (11·9) <0·0001
Height (m) 1·68 (0·09) 1·69 (0·09) 1·68 (0·09) 0·053
BMI (kg/m²) 22·9 (1·6) 27·2 (1·4) 33·2 (3·1) <0·0001
Lipid parameters
Total cholesterol (mmol/L) 5·9 (1·1) 5·7 (1·1) 5·5 (1·2) <0·0001
LDL (mmol/L) 3·6 (0·9) 3·6 (1·0) 3·4 (1·1) <0·0001
HDL (mmol/L) 1·8 (0·4) 1·6 (0·4) 1·4 (0·3) <0·0001
Triglycerides (mmol/L) 0·9 (0·7–1·2) 1·1 (0·8–1·6) 1·3 (1·0–2·0) <0·0001†
Inﬂ ammatory markers
Cystatin C (mg/L) 0·8 (0·1) 0·8 (0·1) 0·8 (0·1) <0·0001
C-reactive protein (mg/L) 2·0 (1·5–3·2) 2·6 (1·8–4·3) 3·2 (2·2–5·1) <0·0001*
Interleukin-6 (pg/mL) 1·4 (1·0–2·4) 1·8 (1·3–2·7) 2·5 (1·7–3·6) <0·0001*
Metabolic markers
Leptin (ng/mL) 7·3 (3·7–12·9) 11·3 (6·4–20·0) 25·4 (12·8–39·7) <0·00001*
Adiponectin (μg/mL) 16·4 (10·7–25·1) 12·7 (6·8–18·3) 9·7 (6·2–15·8) <0·0001*
HbA1c (%) 5·7 (0·4) 5·8 (0·6) 6 (0·9) <0.0001
Diabetes mellitus 14/78 (18%) 28/78 (36%) 36/78 (46%) <0·0001
Socioeconomic status at age 53 years† 
Professional 40 (10%) 43 (9%) 19 (7%) 0·066
Intermediate 187 (47%) 207 (40%) 120 (43%) ··
Skilled (non-manual) 84 (21%) 139 (27%) 53 (19%) ··
Skilled (manual) 48 (12%) 70 (13%) 44 (16%) ··
Partly skilled 33 (85) 48 (9%) 37 (13%) ··
Unskilled 8 (2%) 15 (3%) 8 (3%) ··
Smoking† 
Never smoked 142 (36%) 159 (30%) 100 (36%) 0·058
Ex-smoker 160 (40%) 213 (41%) 93 (33%) ··
Present smoker 96 (24%) 151 (29%) 89 (32%) ··
Receiving blood-pressure drugs 37 (9%) 123 (22%) 86 (29%) <0·0001
Receiving lipid-lowering drugs 42 (10%) 104 (19%) 86 (29%) <0·0001
Physically active since 1982 to 2006–09†
Inactive 37 (10%) 50 (11%) 40 (15%) 0·021
Active at some point 223 (63%) 323 (70%) 167 (64%) ··
Always active 97 (27%) 90 (19%) 53 (20%) ··
Mean intima media thickness (mm) 0·66 (0·11) 0·69 (0·13) 0·71 (0·12) <0·0001
Data are n (%), mean (SD), or n/N (%), unless otherwise indicated. *Kruskal-Wallis test. †X2 test.
Table 1: Participant characteristics by BMI category at the age of 60–64 years 
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adiposity in adulthood had a graded and cumulative 
adverse eﬀ ect on development of vascular disease and 
cardiovascular risk-factor proﬁ le in later life. We have 
also shown, for the ﬁ rst time, that this eﬀ ect was 
attenuated by weight loss suﬃ  cient to drop a BMI 
category from obese to overweight, or overweight to 
normal weight, at any period during adult life. These 
ﬁ ndings emphasise the potential cardiovascular beneﬁ ts 
of clinical and public health strategies that help 
individuals who are overweight and obese to lose weight 
at any age (panel).
Overweight and obese individuals have a higher 
incidence of cardiovascular risk factors (including 
hypertension, type 2 diabetes, and hyperlipidaemia) and 
increased cardiovascular mortality compared with 
participants of a normal weight.20 Exposure to adiposity 
from childhood to early adulthood was associated with 
evidence of early arterial disease in four large cohorts.21 
However, long-term exposure to adiposity in adult life, 
and its cardiovascular eﬀ ect at an age when cardiovascular 
events are likely to take place, have not been previously 
investigated.
In the 1946 British birth cohort, various measures of 
BMI from birth were made and vascular phenotyping 
was undertaken at age 60–64 years with cIMT—a 
reproducible non-invasive measure that is relevant to 
both atherosclerosis progression and adverse cardio-
vascular outcome.22 This technique provided the unique 
opportunity to examine the cardiovascular eﬀ ect of long-
term exposure to adiposity, but also to study patterns of 
BMI change likely to happen during an individual’s 
lifetime. The longer the exposure to adiposity the higher 
the cIMT and the more unfavorable the cardiovascular 
risk-factor proﬁ le in late adulthood. Systolic blood 
pressure was raised and the risk of diabetes increased 
with longer exposure to overweight and obesity in adult 
life. However, the disturbed cardiometabolic and 
inﬂ ammatory risk proﬁ le did not fully account for the 
link between adiposity and cIMT. These ﬁ ndings extend 
previous ﬁ ndings for early adulthood and provide 
important information about the acquisition of adiposity 
at an age where cardiovascular risk is at its highest.21,23 
Unlike previous reports, in our study physical activity did 
not change the association between adiposity and 
cardiovascular phenotype. The use of non-validated 
activity questionnaires could account for this discrepancy, 
even though they closely relate to the physical 
performance of these participants.18,24
The independent contribution of childhood adiposity 
to arterial disease in later life was small in this cohort 
compared with that reported for adolescence.25 We used 
criteria from the International Obesity Taskforce16 to 
deﬁ ne adiposity in childhood; therefore, our results are 
dependent on the cutoﬀ  points used. Furthermore, post-
war environmental and lifestyle inﬂ uences diﬀ ered 
greatly from the present day, and adiposity levels in 
childhood were lower than in recent cohorts.26 Therefore, 
the relative scarcity of eﬀ ect of childhood adiposity in the 
NSHD might not reﬂ ect the present risks of childhood 
obesity.26
The prolonged follow-up of participants beyond middle 
age enabled assessment of patterns of BMI change on 
vascular phenotype. As little as 5–10% weight loss has 
previously been associated with improvements in 
cardiovascular risk-factor proﬁ les and lower 
cardiovascular mortality in clinical trials of pharma-
cotherapy or surgery.27 However, the ﬁ ndings from the 
LOOK AHEAD trial did not show reduced mortality in 
patients with diabetes after intensive lifestyle modi-
ﬁ cation, despite initial weight loss of about 9% and 
improved cardiovascular risk factors.28 However, 
0·60
0·65
0·70
0·75
cI
M
T 
(m
m
)
Adiposity category
Never 
O/O 
(n=285)
O/O 
since 
2006–09 
(n=100)
O/O 
since 
1999 
(n=183)
O/O 
since 
1989 
(n=145)
O/O 
since 
1982 
(n=211)
Lost and
gained 
weight*
(n=158)
Figure 2: Patterns of BMI change in adulthood and cIMT at age 60–64 years
Data expressed as mean cIMT and 95% CI for each BMI group. Test for trend for 
O/O since 1982 to O/O since 09: p<0·0001. Pairwise comparison of never 
O/O versus O/O: p=0·68 since 2009; p=0·033 since 1999; p=0·012 since 1989; 
p<0·0001 since 1982; and lost and gained, p=0·73. Comparison of never lost 
weight (composite of O/O since 2009, since 1999, since 1989 and 1982) versus: 
lost and gained, p=0·002; and never O/O, p=0·001. O/O=overweight or obese. 
*17 participants lost weight and did not regain it.
N Regression 
coeﬃ  cient
95% CI for cIMT p value* p value† 
Childhood O/O 926/1273 –0·0005 –0·02 to 0·01 0·49 0·51
Adulthood O/O 845/1270 0·029 0·01 to 0·04 <0·0001 0·009
Adjusted model‡ 1270 ·· ·· ·· ··
Childhood O/O ·· –0·005 –0·02 to 0·01 0·45 0·48
Adult Obesity O/O ·· 0·029 0·02 to 0·04 <0·0001 0·009
Joint eﬀ ect model§
NW Child NW Adult 123 Reference
NW Child O/O Adult 224 0·042 0·015 to 0·069 0·002 0·004
O/O Child NW Adult 302 0·006 –0·019 to 0·031 0·62 0·37
O/O Child O/O Adult 621 0·031 0·007 to 0·054 0·011 0·051
O/O=overweight or obesity. N/W=normal weight. *Adjusted for sex. †Fully adjusted. ‡Adjusted for sex, LDL cholesterol, 
smoking, heart rate, systolic blood pressure at 60–64 years, and socioeconomic class at 53 years. §Joint effect model 
between childhood O/O and adulthood O/O (p=0·26).
Table 2: Childhood and adulthood overweight or obesity and carotid intima media thickness at age 
60–64 years
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intervention studies only permit short-term assessment, 
and longer follow up (ie, decades) is necessary to fully 
capture the vascular eﬀ ects of weight change. Our study, 
in which individuals were followed-up over their lifetime 
for more than 60 years, allowed assessment of the eﬀ ect 
of modest, real-life, non-trial-induced, changes in 
adiposity proﬁ le.
We noted an improvement in metabolic proﬁ le, with 
lower concentrations of leptin and HbA1c and higher 
concentrations of adiponectin, in participants who 
dropped a BMI category during adulthood, even when 
this reduction was not sustained. We recorded no eﬀ ect 
on the prevalence of type 2 diabetes. However, the 
association between weight change and development of 
type 2 diabetes is complex. In a meta-analysis, at- risk 
individuals had a reduced incidence of diabetes after 
modest weight loss, even if weight loss was not sustained, 
although smaller studies suggested that weight cycling is 
associated with adverse metabolic proﬁ le and with 
increased risk of type 2 diabetes in later life.29
The mechanisms by which weight changes aﬀ ect the 
arterial wall remain speculative, because most studies to 
date have focused on intentional weight loss with 
pharmacological or surgical interventions. Enhanced 
insulin sensitivity, reduction in inﬂ ammatory cytokines 
and adipokines, mobilisation of fatty acids, hormonal 
changes, and improvement in cardiovascular risk factors, 
might have contributed to the cardiovascular beneﬁ t we 
noted with weight loss.30
Our study has limitations, because we only had BMI 
measured at a restricted number of time points up to 
10 years apart. We were thus unable to identify the eﬀ ect of 
duration of weight loss or weight cycling on cardiovascular 
health. Although we were able to adjust for various 
potential confounders, residual confounding by long-term 
lifestyle patterns and other possible unmeasured variables 
cannot be excluded. The NSHD study lacks ethnic diversity 
(mostly white participants) and the cohort had low levels of 
obesity in childhood and early adulthood compared with 
other cohorts and hence caution is needed when these 
ﬁ ndings are generalised to more recent and more 
ethnically diverse populations. Missing data is unavoidable 
in long-running studies, such as NSHD, and the sample 
with cIMT had a lower baseline cardiovascular risk proﬁ le 
than did those who were excluded. Despite this lower risk, 
we still noted strong associations between patterns of BMI 
change and cIMT in later life. The fairly small sample size 
and therefore low statistical power means we cannot yet 
assess the eﬀ ect of patterns of change in overweight in 
adulthood and coronary heart disease and stroke. Our 
ﬁ ndings suggest that weight reduction or reduced 
exposure to adiposity might translate to long-term 
cardiovascular beneﬁ t. Findings from a meta-analysis 
suggest that a 0·1 mm diﬀ erence in cIMT is associated 
with a hazard ratio of 1·15 for myocardial infarction and of 
1·18 for stroke. Therefore, the mean diﬀ erence of 0·034 
mm in cIMT between participants who lost weight in 
adulthood compared with those who were always 
overweight or obese translates to a reduction of roughly 
9% in rate for both stroke and myocardial infarction.22
In conclusion, our ﬁ ndings suggest that cardiovascular 
beneﬁ t might arise from weight loss in adulthood, 
irrespective of when this weight loss is achieved, and 
support public health policies for lifestyle modiﬁ cations 
for prevention and management of overweight and obese 
individuals at all ages.
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Panel: Research in context
Systematic review
We searched PubMed for research articles and reviews in 
English published up to January, 2014. We used the search 
terms “adiposity”, “weight gain”, “weight loss”, 
“cardiovascular disease”, and “type 2 diabetes”. We also 
retrieved papers from the reference lists of identiﬁ ed articles 
about the link between exposure to adiposity and weight loss 
and cardiovascular disease and type 2 diabetes. Consistent 
evidence exists that longer exposure to adiposity is associated 
with higher risk of coronary heart disease, whereas for the risk 
of type 2 diabetes some evidence suggests that recent 
adiposity status is more important than duration. 
Inconsistencies exist in the literature regarding the eﬀ ect of 
weight cycling. Some epidemiological studies show increases 
in cardiovascular mortality related to weight cycling, whereas 
experimental studies contradict these results. The 
confounding eﬀ ect of health status has been suggested as the 
explanation for these discrepancies.
Interpretation
Our ﬁ ndings show that longer exposure to adiposity has a 
graded and cumulative adverse eﬀ ect on cIMT and 
cardiovascular risk factors in later adulthood. Furthermore, 
we noted that reductions in BMI category, from obese to 
overweight or overweight to normal weight at any period 
during adult life even if not sustained, attenuated these 
adverse eﬀ ects. These ﬁ ndings suggest that weight loss at 
any period in adult life could result in long-term 
cardiovascular beneﬁ t.
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